心血管病防治知识(下半月)
心血管病防治知識(下半月)
심혈관병방치지식(하반월)
XINXUEGUANBING FANGZHI ZHISHI
2014年
2期
47-49
,共3页
心源性猝死%心肌病%危险因素
心源性猝死%心肌病%危險因素
심원성졸사%심기병%위험인소
Sudden cardiac death%Cardiomyopathy%Risk factor
目的:探讨和分析心源性猝的危险因素。方法收集和整理在我院2012年04月-2013年10月诊治时发生心源性猝死的心肌患者64例为研究对象,对上述收集对象的临床资料进行整理和分析。结果本组单因素分析显示自发性持续室速、心室颤动(心脏骤停)、晕阙、左室流出道梗阻、非持续性室速等因素为心肌疾病患者发生心源性猝死的危险因素;多因素Logistic分析发现自发性持续性室速、心室颤动、晕阙以及猝死家族史是发生心源性猝死的重要危险因素。结论心肌疾病患者发生心源性猝死的为危险因素呈现综合化、多样化,临床治疗中应给予针对性的预防或治疗,这对降低心肌疾病患者心源性猝死率有着积极的意义。
目的:探討和分析心源性猝的危險因素。方法收集和整理在我院2012年04月-2013年10月診治時髮生心源性猝死的心肌患者64例為研究對象,對上述收集對象的臨床資料進行整理和分析。結果本組單因素分析顯示自髮性持續室速、心室顫動(心髒驟停)、暈闕、左室流齣道梗阻、非持續性室速等因素為心肌疾病患者髮生心源性猝死的危險因素;多因素Logistic分析髮現自髮性持續性室速、心室顫動、暈闕以及猝死傢族史是髮生心源性猝死的重要危險因素。結論心肌疾病患者髮生心源性猝死的為危險因素呈現綜閤化、多樣化,臨床治療中應給予針對性的預防或治療,這對降低心肌疾病患者心源性猝死率有著積極的意義。
목적:탐토화분석심원성졸적위험인소。방법수집화정리재아원2012년04월-2013년10월진치시발생심원성졸사적심기환자64례위연구대상,대상술수집대상적림상자료진행정리화분석。결과본조단인소분석현시자발성지속실속、심실전동(심장취정)、훈궐、좌실류출도경조、비지속성실속등인소위심기질병환자발생심원성졸사적위험인소;다인소Logistic분석발현자발성지속성실속、심실전동、훈궐이급졸사가족사시발생심원성졸사적중요위험인소。결론심기질병환자발생심원성졸사적위위험인소정현종합화、다양화,림상치료중응급여침대성적예방혹치료,저대강저심기질병환자심원성졸사솔유착적겁적의의。
Objective To investigate and analyze the risk factors for sudden cardiac death. Methods Sixty-four patients with cardiomyopathy who suffered sudden cardiac death in our hospital from April 2012 to October 2013 were collected as subjects, and their clinical data were sorted and analyzed. Results The univariate analysis showed that the risk factors for sudden cardiac death in patients with cardiomyopathy included spontaneous sustained ventricular tachycardia, ventricular fibrillation (sudden cardiac arrest), syncope, left ventricular outflow tract obstruction, and nonsustained ventricular tachycardia. The multivariate logistic analysis showed that spontaneous sustained ventricular tachycardia, ventricular fibrillation, syncope, and a family history of sudden death were important risk factors for sudden cardiac death. Conclusion The risk factors for sudden cardiac death in patients with cardiomyopathy are complicated and diverse, and specific prevention or treatment should be adopted in clinical treatment, which is of great significance for reducing the incidence of sudden cardiac death in patients with cardiomyopathy.